• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib.

作者信息

Valent Jason N, Schiffer Charles A

出版信息

Leuk Res. 2011 Jan;35(1):e1-3. doi: 10.1016/j.leukres.2010.08.022.

DOI:10.1016/j.leukres.2010.08.022
PMID:20888043
Abstract
摘要

相似文献

1
Prevalence of large granular lymphocytosis in patients with chronic myelogenous leukemia (CML) treated with dasatinib.达沙替尼治疗的慢性粒细胞白血病（CML）患者中大颗粒淋巴细胞增多症的患病率。
Leuk Res. 2011 Jan;35(1):e1-3. doi: 10.1016/j.leukres.2010.08.022.
2
Y253H mutation appearing in a micro-BCR-ABL (e19a2) CML.
Leuk Res. 2008 Feb;32(2):361-2. doi: 10.1016/j.leukres.2007.03.001. Epub 2007 Apr 6.
3
Natural killer or natural killer/T cell lineage large granular lymphocytosis associated with dasatinib therapy for Philadelphia chromosome positive leukemia.与达沙替尼治疗费城染色体阳性白血病相关的自然杀伤细胞或自然杀伤细胞/T细胞系大颗粒淋巴细胞增多症。
Haematologica. 2009 Jan;94(1):135-9. doi: 10.3324/haematol.13151. Epub 2008 Dec 9.
4
Successful treatment using low-dose dasatinib for chronic myelogenous leukemia in a patient with megakaryoblastic transformation concomitant with myelofibrosis and an extramedullary tumor.
Leuk Res. 2010 Sep;34(9):e237-9. doi: 10.1016/j.leukres.2010.03.024. Epub 2010 Apr 3.
5
Promyelocytic blast crisis of chronic myelogenous leukemia during imatinib treatment.
Acta Haematol. 2007;117(4):236-7. doi: 10.1159/000099548. Epub 2007 Feb 14.
6
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
7
Large granular lymphocytosis during dasatinib therapy.达沙替尼治疗期间出现大颗粒淋巴细胞增多症。
Cancer Biol Ther. 2014 Mar 1;15(3):247-55. doi: 10.4161/cbt.27310. Epub 2013 Dec 18.
8
Retrospective multicenter study on the development of peripheral lymphocytosis following second-line dasatinib therapy for chronic myeloid leukemia.二线达沙替尼治疗慢性髓性白血病后外周血淋巴细胞增多的回顾性多中心研究。
Am J Hematol. 2011 Apr;86(4):346-50. doi: 10.1002/ajh.21980.
9
A T315I mutation in e19a2 BCR/ABL1 chronic myeloid leukemia responding to dasatinib.对达沙替尼有反应的e19a2 BCR/ABL1慢性髓性白血病中的T315I突变。
Leuk Res. 2010 Sep;34(9):e240-2. doi: 10.1016/j.leukres.2010.03.036. Epub 2010 May 5.
10
Dasatinib in chronic myelogenous leukemia.达沙替尼治疗慢性粒细胞白血病
N Engl J Med. 2006 Sep 7;355(10):1062-3; author reply 1063-4.

引用本文的文献

1
Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness.持续性大颗粒淋巴细胞克隆性扩增：“万恶之源”——也是一些益处之源。
Cancers (Basel). 2022 Mar 5;14(5):1340. doi: 10.3390/cancers14051340.
2
Synergistic anti-tumor effects of dasatinib and dendritic cell vaccine on metastatic breast cancer in a mouse model.达沙替尼与树突状细胞疫苗对小鼠模型转移性乳腺癌的协同抗肿瘤作用
Oncol Lett. 2018 May;15(5):6831-6838. doi: 10.3892/ol.2018.8188. Epub 2018 Mar 7.
3
Lymphocytosis after treatment with dasatinib in chronic myeloid leukemia: Effects on response and toxicity.
达沙替尼治疗慢性髓性白血病后的淋巴细胞增多：对反应和毒性的影响。
Cancer. 2016 May 1;122(9):1398-407. doi: 10.1002/cncr.29933. Epub 2016 Mar 21.
4
Dasatinib promotes Th1-type responses in granzyme B expressing T-cells.达沙替尼在表达颗粒酶B的T细胞中促进Th1型反应。
Oncoimmunology. 2014 May 29;3:e28925. doi: 10.4161/onci.28925. eCollection 2014.
5
Large granular lymphocytosis during dasatinib therapy.达沙替尼治疗期间出现大颗粒淋巴细胞增多症。
Cancer Biol Ther. 2014 Mar 1;15(3):247-55. doi: 10.4161/cbt.27310. Epub 2013 Dec 18.
6
Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.早在 1 个月时淋巴细胞的相对增加可预测慢性期慢性髓性白血病对达沙替尼的反应改善。
Int J Hematol. 2014 Jan;99(1):41-52. doi: 10.1007/s12185-013-1483-9. Epub 2013 Dec 3.
7
Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients.达沙替尼治疗慢性髓性白血病患者中出现大颗粒淋巴细胞快速且持续增加和罕见的巨细胞病毒再激活。
Int J Hematol. 2012 Sep;96(3):308-19. doi: 10.1007/s12185-012-1132-8. Epub 2012 Jul 6.